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STUDY PROTOCOL Open Access
The epidemiology of food allergy in Europe:
protocol for a systematic review
Bright I Nwaru1, Sukhmeet S Panesar2, Lennart Hickstein3, Tamara Rader4, Thomas Werfel5, Antonella Muraro6,
Karin Hoffmann-Sommergruber7, Graham Roberts8 and Aziz Sheikh2* on behalf of European Academy of Allergy
and Clinical Immunology Food Allergy and Anaphylaxis Guidelines group
Abstract
Background: The European Academy of Allergy and Clinical Immunology is in the process of developing its
Guideline for Food Allergy and Anaphylaxis, and this protocol of a systematic review is one of seven inter-linked
evidence syntheses that are being undertaken in order to provide a state-of-the-art synopsis of the current
evidence base in relation to epidemiology, prevention, diagnosis and clinical management and impact on quality of
life, which will be used to inform the formulation of clinical recommendations.
The aims of the systematic review will be to understand and describe the epidemiology of food allergy, i.e. frequency,
risk factors and outcomes of patients suffering from food allergy, and to describe how these characteristics vary by
person, place and time.
Methods: A highly sensitive search strategy has been developed to retrieve articles that have investigated the various
aspects of the epidemiology of food allergy. The search will be implemented by combining the concepts of food
allergy and its epidemiology from electronic bibliographic databases.
Discussion: This systematic review will provide the most up to date estimates of the frequency of food allergy in
Europe. We will attempt to break these down by age and geographical region in Europe. Our analysis will take into
account the suitability of the study design and the respective study biases that could affect exposure and outcome.
We will examine the different methods to diagnose food allergy and the associated measures of occurrence.
Keywords: Food allergy, IgE-mediated, Risk, Anaphylaxis, Epidemiology, Prevalence, Incidence
Background
The umbrella term ‘food hypersensitivity’ can be used to
describe any ‘adverse reaction to food’ [1]. The term ‘food
allergy’ refers to the sub-group of food-triggered reactions
in which immunological mechanisms have been implicated,
whether IgE-mediated, non-IgE-mediated, or involving a
combination of IgE- and non-IgE-mediated etiologies [2].
All other reactions to food that were in the past sometimes
referred to as ‘food intolerance’ constitute non-allergic food
hypersensitivity reactions and are out of the focus of this
enquiry.
Allergic sensitisation to a specific food does not always
lead to clinical reactions. Consequently, serological tests
for food-specific IgE or the determination of positive skin
prick test results are of themselves insufficient to establish
the diagnosis of food allergy. Rather, there must also be
evidence of the clinical expression of disease. IgE-mediated
reactions can, for example, manifest as angioedema, urti-
caria, atopic eczema/dermatitis, oral allergy syndrome and
anaphylaxis. Non-IgE-mediated immunological reactions
result from activation of other immunological pathways
(e.g., T-cell mediated) and can manifest as atopic eczema/
dermatitis, gastro-esophageal reflux disease, food protein-
induced enterocolitis, proctocolitis and enteropathy syn-
dromes. The contemporary definition of food allergy thus
includes several clinical entities with different pathophysi-
ologies (see Table 1) resulting from exposure to different
foods. Coeliac disease is an important non-IgE mediated
condition but as it has distinct symptoms and prognosis
different from atopic conditions it will be excluded from
this review [3].
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Uncertainty in estimating the incidence and prevalence
of food allergy is in part due to changing definitions and
imprecision in terminology, with investigators often failing
to make clear whether they are studying food hypersensi-
tivity in general, IgE-mediated conditions, non-IgE medi-
ated morbidities, or some combination or subset of these
reactions. Another major contributing factor to this un-
certainty is that relatively few epidemiological studies have
utilised the gold standard of diagnosis – the double-blind,
placebo-controlled food challenge (DBPCFC) [4-10]. Ra-
ther, many studies have based their estimates of the fre-
quency of food allergy on measurements of lay/patient
perceptions of food allergy, which are known to substan-
tially overestimate the actual frequency [11-21]. There is
clearly a need for large, population-based, longitudinal
studies employing DBPCFCs to secure the diagnosis of
food allergy, [22] but in the interim there is also a need to
make better sense of the extant literature in order to,
amongst other things, inform estimates on the frequency
of the disease, provide insights into disease aetiology, and
enable risk stratification, which can be used to inform
management decisions and deliberations on prognosis.
Epidemiological measures of particular interest for
food allergy therefore include estimates of incidence and
prevalence, risk and prognostic factors, and risk of re-
currence and death. The following epidemiological defi-
nitions proposed by Last, and adapted for food allergy
will be employed in this review [23].
Incidence
The number of new cases of the various IgE-mediated,
non-IgE-mediated or combination causes of food allergy
that occur during a given period in a defined population.
Incidence will be studied as:
– Incidence rate: The number of new cases of food
allergy that occur during a given period per unit of
person-time.
– Cumulative incidence: The number of new cases of
food allergy that occur during a given period per the
population at risk.
Prevalence
The proportion of a defined population known to have
experienced the various IgE-mediated, non-IgE-mediated
or combination causes of food allergy. Care is required
in defining the appropriate denominator. This epidemio-
logical measure will be further divided into:
 Point prevalence: the proportion of the population
that has experienced food allergy at a specific time.
 Period prevalence: the proportion of the population
that has experienced food allergy during a given period.
 Lifetime : the proportion of the population that at
some point in their life will have experienced food
allergy.
Case fatality rate
The proportion of cases of anaphylaxis that proves fatal
(usually defined within a time period). This is also some-
times known as the case fatality ratio.
The European Academy of Allergy and Clinical Im-
munology (EAACI) is in the process of developing the
EAACI Guideline for Food Allergy and Anaphylaxis, and
this systematic review is one of seven inter-linked evi-
dence syntheses that are being undertaken in order to
provide a state-of-the-art synopsis of the current evidence
base in relation to epidemiology, prevention, diagnosis
and clinical management and impact on quality of life,
which will be used to inform the formulation of clinical
recommendations.
The aims of this systematic review will be to:
 Understand and describe the epidemiology of food
allergy, i.e. frequency, risk factors and outcomes of
patients suffering from food allergy
 Describe how these characteristics vary by person,
place and time.
Methods
Search strategy
A highly sensitive search strategy has been developed to
retrieve articles that have investigated the various
Table 1 Pathologies with respective disorders seen in
food allergy
Pathology Disorder
IgE-mediated (acute-onset) ● Atopic eczema/dermatitis
● Wheals, angioedema or both
● Contact urticaria
● Anaphylaxis
● Food-associated, exercise-induced
anaphylaxis
● Oral allergy syndrome (pollen-
associated food allergy syndrome)
● Immediate gastrointestinal
hypersensitivity
Cell-mediated (delayed onset/
chronic)
● Atopic eczema/dermatitis
● Food protein-induced enterocolitis
syndrome
● Food protein-induced allergic
proctocolitis
● Allergic contact dermatitis
● Heiner syndrome
Combined IgE and cell-mediated
(delayed onset/chronic)
● Atopic eczema/dermatitis
● Eosinophilic oesophagitis
● Eosinophilic gastroenteritis
Nwaru et al. Clinical and Translational Allergy 2013, 3:13 Page 2 of 5
http://www.ctajournal.com/content/3/1/13
aspects of the epidemiology of food allergy. The search
will be implemented by combining the concepts of food
allergy and its epidemiology from electronic biblio-
graphic databases. We have conceptualised the search to
incorporate the three elements below as shown in
Figure 1: Conceptualisation of systematic review on the
epidemiology of food allergy.
To retrieve systematic reviews, we will use the system-
atic review filter developed at McMaster University
Health Information Research Unit [24]. We have also
adapted the search filter from York University Centre
for Reviews and Dissemination [25] to retrieve inci-
dence, prevalence and other characteristics describing
the epidemiology of food allergy. Similarly, we also ap-
plied the McMaster filter for prognosis studies [26].
We will search the following databases:
 MEDLINE (OVID)
 Embase (OVID)
 CINAHL (Ebscohost)
 ISI Web of Science (Thomson Web of Knowledge)
The search strategy has been devised on OVID
MEDLINE and then adapted for the other databases (see
Additional file 1 for full search strategies). In all cases the
databases will be searched from 1 January 2000 to 30
September 2012, and limited to Europe based on the
definition provided by the Organization for Economic Co-
operation and Development (OECD) [27]. The countries
covered by this restriction include Austria, Belgium, Czech
Republic, Denmark, Estonia, Finland, France, Germany,
Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, the
Netherlands, Norway, Poland, Portugal, Slovak Republic,
Slovenia, Spain, Sweden, Switzerland, Turkey and the
United Kingdom. All references will be imported into an
EndNote Library and tagged with the name of the
database. Searches will be limited to literature from 2000
onwards as we want to study the contemporary epidemi-
ology of food allergy.
Additional references will be located through searching
the references cited by the identified studies, and unpub-
lished work and research in progress will be identified
through discussion with experts in the field. We will invite
experts who are active in the field from a range of
disciplines and geography to comment on our search
strategy, and the list of included studies. There are no
language restrictions and, where possible, all literature
will be translated. We will report any literature which
we are unable to translate.
Inclusion criteria for study designs
 Systematic reviews and meta-analyses
 Cross-sectional studies
 Case–control studies
 Cohort studies
 Routine healthcare studies
These study designs were chosen to ensure that the
highest levels of evidence were pooled based on the aims
of this review [28].
Exclusion criteria for study designs
 Reviews, discussion papers, non-research letters and
editorials
Condition
• Food allergy
Study designs
• Systematic reviews 
+/-meta-analyses 
• Cohort studies
• Cross-sectional 
studies
• Case-control 
studies
• Routine healthcare 
studies
Outcomes
• Incidence:
• Incidence rate
• Cumulative 
incidence
• Prevalence:
• Point prevalence
• Period prevalence
• Lifetime  
prevalence
• Risk factors
• Case-fatality rate
Figure 1 Conceptualisation of systematic review on the epidemiology of food allergy.
Nwaru et al. Clinical and Translational Allergy 2013, 3:13 Page 3 of 5
http://www.ctajournal.com/content/3/1/13
 Case studies and case series
 Animal studies
Outcome assessment
Recognising that varied methods of assessments have been
used to define food allergy across different studies, in esti-
mating the frequency of the disease, we will include all
possible methods that have been used by the primary
studies to be included in the review, which include studies
with self-reported assessment, clinician diagnosis, allergic
sensitisation (based on skin prick test, specific IgE mea-
surement, skin atopy patch test, and other radioallergosor-
bent test (RAST) measurements), and food challenges
(open food challenge, one blinded food challenge, and
double-blind place-controlled food challenge). For the
synthesis of the studies on the risk and prognostic factors
for food allergy, we will include only the studies that have
studied objectively-verified (food challenges) food allergy
as an outcome, as this will constitute the strongest evi-
dence in terms of highlighting potential causal link be-
tween the risk factors and food allergy.
Study selection
The titles of the retrieved articles will be checked inde-
pendently by two reviewers according to the above selec-
tion criteria and categorised as: included, not included
and unsure. For those papers in the unsure category, we
will retrieve the abstract and re-categorise as above after
further discussion on them. Any discrepancies will be re-
solved by consensus and if necessary a third reviewer will
be consulted to arbitrate. Full text copies of potentially
relevant studies will be obtained and their eligibility for in-
clusion independently assessed by two reviewers. Studies
that do not fulfil all of the inclusion criteria will be
excluded.
Risk of bias assessment strategy
Risk of bias assessments will independently be carried out
on each study by two reviewers using an adapted and
modified relevant version of the Critical Appraisal Skills
Programme (CASP) quality assessment tool for systematic
reviews [29], cohort studies and cross-sectional [30] and
case–control studies [31], which involves an assessment of
both internal and external validity [32]. An overall grading
and grading for the various components of each study (e.g.
the appropriateness of the study design for the research
question, the risk of selection bias, exposure measurement,
and outcome assessment) will be given to each study. Any
discrepancies will be resolved by discussion or, if agree-
ment could not be reached, by arbitration by a third
reviewer.
Analysis, data synthesis and reporting
Data will be independently extracted onto a customised
data extraction sheet by two reviewers, and any discrep-
ancies will be resolved by discussion or, if agreement
could not be reached, by arbitration by a third reviewer.
A descriptive summary with data tables will be produced
to summarise the literature. If clinically and statistically
appropriate, meta-analysis using either fixed-effect or
random-effects modelling will be undertaken using
methods suggested by Agresti and Coul [33]. A narrative
synthesis of the data will also be undertaken.
This review has been registered with the International
Prospective Register of Systematic Reviews (PROSPERO)
and has the registration number CRD42013003704 allo-
cated to it. The Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) checklist will be
used to guide the reporting of the systematic review [34].
Discussion
This systematic synthesis of studies published between
January 2000 and September 2012 will provide estimates
of the frequency of food allergy across different age groups
and geographical regions in Europe. It will take into ac-
count the suitability of the study design for the research
question, potential for selection bias, and the methods of
exposure and outcome assessments. One strength of the
review is that we will be able to examine all the different
methods that have been used to measure food allergy
(self-report, specific sensitization to food allergens, and
food challenges, and their various combinations) as well
as the different measures of occurrence of food allergy
(point prevalence, life-time prevalence, and incidence),
which will give us the opportunity to study different esti-
mates of the frequency of food allergy according to these
varied definitions.
Additional file
Additional file 1: Search strategies.
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